FDA cleared Amneal’s generic lanreotide, and it launched immediately. Why more competition has not yet cut what patients pay for monthly injections.
Amneal Launches Its Generic Lanreotide Immediately While the Brand Still Posts Nearly a Billion in US Sales
by | Sep 20, 2026 | Uncategorized | 0 comments

Recent Comments